Vaccine Development

Jun 22, 2018
By BioPharm International Editors
The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.
Jun 14, 2018
By BioPharm International Editors
Microbiologists from the University of Connecticut have pinpointed exterior proteins on syphilis-causing bacteria that could serve as vaccine targets for syphilis.
Jun 04, 2018
By BioPharm International Editors
The Future Vaccine Manufacturing Hub will work with CPI as well as other UK institutions to address challenges of vaccine production and distribution so that the spread of new diseases can be effectively tackled.
May 30, 2018
By BioPharm International Editors
World Health Organization’s Ebola ring vaccination uses Merck & Co.’s investigational rVSV-ZEBOV vaccine to protect high-risk communities in the Democratic Republic of the Congo from Ebola.
May 09, 2018
By BioPharm International Editors
The companies expanded their partnership to develop and commercialize messenger RNA (mRNA) cancer vaccines to include shared-antigen mRNA cancer vaccines such as mRNA-5671.
May 02, 2018
Public health authorities and the biomedical research community are seeking new strategies to address global health threats.
Apr 30, 2018
By BioPharm International Editors
The agency updated its list of recommended influenza virus strains that manufacturers should include in vaccines for the autumn 2018 season.
Apr 12, 2018
By BioPharm International Editors
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
Apr 01, 2018
BioPharm International
Accelerated development of new preventives raises challenges for efficient CMC evaluation and production.
Mar 08, 2018
By BioPharm International Editors
GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.
native1_300x100
lorem ipsum